TY - CHAP
T1 - Overview of the current knowledge and challenges associated with human exposure to nanomaterials
AU - Kermanizadeh, Ali
AU - Jantzen, Kim
AU - Skovmand, Astrid
AU - Damião Gouveia, Ana Cecília
AU - Jacobsen, Nicklas Raun
AU - Stone, Vicki
AU - Clift, Martin J. D.
PY - 2017
Y1 - 2017
N2 - There has been significant progress in the field of nanotoxicology, which has coincided with the increasing advancements made in the field of nanotechnology (Donaldson et al., 2006; Hoet et al., 2004; Maynard et al., 2006; 2007). Due to the increased use and diversity of nanomaterials (NM) there is an imperative need to deduce whether NM exposure could result in the onset of adverse human health effects. In order to address such health 776concerns, research into the effects of engineered NMs has received considerable interest over the past 20 years. This research has provided important information that has enabled the progression and realisation of some of proposed advantages of nanotechnology (Maynard et al., 2006; 2007; Oberdorster et al., 2005). Currently, despite certain advances in the field of nanotoxicology, the testing strategies for the determination of the NM-related biological impact(s) remain insufficient (Oberdorster et al., 2005).
AB - There has been significant progress in the field of nanotoxicology, which has coincided with the increasing advancements made in the field of nanotechnology (Donaldson et al., 2006; Hoet et al., 2004; Maynard et al., 2006; 2007). Due to the increased use and diversity of nanomaterials (NM) there is an imperative need to deduce whether NM exposure could result in the onset of adverse human health effects. In order to address such health 776concerns, research into the effects of engineered NMs has received considerable interest over the past 20 years. This research has provided important information that has enabled the progression and realisation of some of proposed advantages of nanotechnology (Maynard et al., 2006; 2007; Oberdorster et al., 2005). Currently, despite certain advances in the field of nanotoxicology, the testing strategies for the determination of the NM-related biological impact(s) remain insufficient (Oberdorster et al., 2005).
UR - http://www.scopus.com/inward/record.url?scp=85054207960&partnerID=8YFLogxK
U2 - 10.1201/9781315196602
DO - 10.1201/9781315196602
M3 - Chapter
AN - SCOPUS:85054207960
SN - 9789814613699
T3 - Pan Stanford Series on Biocatalysis
SP - 775
EP - 810
BT - Biocatalysis and Nanotechnology
A2 - Grunwald, Peter
PB - Pan Stanford Publishing
ER -